Bayer AG - Annual Report 2006

Financial Statements

8. Net Sales

Sales revenues are derived primarily from product deliveries. Total reported net sales increased by €4,255 million or 17.2 percent from 2005 to €28,956 million. While volumes increased by €1,145 million, or 4.7 percent, adverse shifts in exchange rates trimmed sales by €47 million, or 0.2 percent. Changes in selling prices contributed €132 million, or 0.5 percent, to the growth in business. Portfolio changes boosted sales by €3,025 million, or 12.2 percent.

Portfolio changes led to the following changes in sales compared with the previous year:


€ million
Acquisitions
Schering AG, Berlin, Germany	3,082
Other	24
	3,106
Divestitures
Cessation of plasma distribution in Canada (divested in 2005)	(100)
CropScience active ingredients	(50)
	(150)
Lanxess sales revenues (January 1-31, 2005)	69
Net effect of portfolio changes	3,025

Breakdowns of net sales by segment and by region are given in the table in Note [1].

back to overview